InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,509.01
(
0.62%
)
US TECH 100
19,460.00
(
0.95%
)
Dow Jones
39,331.85
(
0.41%
)
Brent Oil
86.27
(
-0.20%
)
Bitcoin
62,109.04
(
0.13%
)
Post# of 252466
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

drbio45

Send PM Follow Ignore
Followers 36
Posts 3185
Boards Moderated 0
Alias Born 10/18/2003

drbio45

Re: DewDiligence post# 20710

Saturday, 12/17/2005 10:45:08 PM

Saturday, December 17, 2005 10:45:08 PM

Post# of 252466
Do you mean the lack of interaction with warfarin (which was reported in MYOG’s PR)? This has also been cited by Actelion as an advantage of Tracleer vis-à-vis ENCY’s Thelin.

I meant warfarin, easy to mix the two up.
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up